Literature DB >> 11814014

Characterization of glycans in a lactoferrin isoform, lactoferrin-a.

Z Wei1, T Nishimura, S Yoshida.   

Abstract

The presence of glycan at Asn-281 in bovine lactoferrin-a, which has a higher molecular weight than regular lactoferrin-b, was found in our previous study. The present work was performed to clarify the structures of the glycans linked to the five N-glycosylation sites in lactoferrin-a and to compare them with those of glycans linked to lactoferrin-b. In lactoferrin-a, the glycans linked to Asn-233 and Asn-545 were of the high-mannose type, whereas those present at Asn-368 and Asn-476 were complex-type ones. These glycans possessed heterogeneous structures. A comparative study of the glycans on bovine lactoferrin-a and bovine lactoferrin-b by HPLC showed that the structures of the glycans linked to Asn-368, Asn-476, and Asn-545 were very similar, the exception being the glycan linked to Asn-233. In addition, analysis of the structure of the glycan bound to Asn-281 present only in lactoferrin-a showed it possessed the heterogeneous structure of a complex-type glycan in which the structures Man3GlcNAc2, Man3GlcNAc4, Man3GlcNAc4Fuc are suggested to be present based on HPLC retention times only.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11814014     DOI: 10.3168/jds.S0022-0302(01)74712-1

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  8 in total

1.  Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles.

Authors:  Katrin Sparbier; Sonja Koch; Irina Kessler; Thomas Wenzel; Markus Kostrzewa
Journal:  J Biomol Tech       Date:  2005-12

2.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  Effects of CHO-expressed recombinant lactoferrins on mouse dendritic cell presentation and function.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Innate Immun       Date:  2014-12-23       Impact factor: 2.680

4.  Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases.

Authors:  Kevin A Glenn; Rick F Nelson; Hsiang M Wen; Adam J Mallinger; Henry L Paulson
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

5.  Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.

Authors:  Byung-Kwon Choi; Jeffrey K Actor; Sandra Rios; Marc d'Anjou; Terrance A Stadheim; Shannon Warburton; Erin Giaccone; Michael Cukan; Huijuan Li; Angela Kull; Nathan Sharkey; Paul Gollnick; Maja Kocieba; Jolanta Artym; Michal Zimecki; Marian L Kruzel; Stefan Wildt
Journal:  Glycoconj J       Date:  2008-03-26       Impact factor: 2.916

Review 6.  Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

Authors:  Jeffrey K Actor
Journal:  Mediators Inflamm       Date:  2015-12-14       Impact factor: 4.711

Review 7.  Studying Lactoferrin N-Glycosylation.

Authors:  Sercan Karav; J Bruce German; Camille Rouquié; Annabelle Le Parc; Daniela Barile
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

8.  Site-specific N-glycosylation analysis: matrix-assisted laser desorption/ionization quadrupole-quadrupole time-of-flight tandem mass spectral signatures for recognition and identification of glycopeptides.

Authors:  Oleg Krokhin; Werner Ens; Kenneth G Standing; John Wilkins; Hélène Perreault
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.